Bad Drugs Are Looking Good
Setup
Ketamine has sometimes been called the “date rape drug” because its sedative properties have enabled sexual assaults — but a groundbreaking study suggests it can also reduce symptoms of depression. Psychedelic drugs, such as psilocybin and LSD, can trigger a schizophrenic episode, but their potential to treat addiction, control post-traumatic stress disorder, and prepare terminally ill patients for death is intriguing. And while marijuana is a controlled substance under federal law, 33 states allow it to be sold for medical uses (and 11 say it’s okay for recreation). Researchers are taking a fresh look at the treatment value of drugs with a reputation for danger and making some surprising discoveries.
- 2019 Health
Is there such a thing as a bad drug?
Moderator John Torres, medical correspondent for NBC news, wants to know if the categorization of some drugs as “bad” drugs is warranted, and the panel responds unanimously:
Drugs are never inherently bad, explains Rick Doblin, founder of the Multidisciplinary Association for Psychedelic Studies. It’s our relationship to drugs and the properties we choose to associate them with that can become problematic. These relationships are not fixed, says Doblin; they can evolve over time as science and society progress.
The science behind marijuana as a treatment for PTSD
Marijuana is is undergoing a complete reinvention from the days of Reefer Madness, and it’s already showing compelling results as a medicine. Mallory Loflin, research scientist at the Department of Veteran Affairs, is pioneering research into how cannabinoids — the specific compounds found in marijuana — could profoundly change how we treat PTSD.
How it works
Rick Doblin follows up Loflin's explanation with a reminder of the difficulties faced by researchers like Loflin in studying “bad” drugs, marijuana included. Because of their dubious reputations, regulatory quagmires often impede the ability of researchers to effectively study these drugs even in controlled environments.
Drugs are a tool, not a panacea
While it’s true that drugs like ketamine and MDMA have produced incredible results when used to treat some mental illnesses, Dennis Charney, dean of the Icahn School of Medicine, and Mallory Loflin want us to remember that they’re almost always used in conjunction with therapy and other treatments:
Claims about drugs can easily outpace research
Somewhat ironically, some “bad” drugs are shedding their notorious reputations and gaining reputations that drastically overstate their safe and effective usage. The panel explains, using examples from their own research, how this can quickly become problematic:
Learn More
Additional Information
Explore More
USA
Global conflicts and health crises have put into stark relief deeply-ingrained gender roles in society. Yet the past years have also seen record-high numbers of women running...
The world seems to be moving and evolving faster than ever before, and democratic ideals are under threat in many countries around the globe. New York Times columnist and jour...
How is constitutional law being harnessed to address climate change? Ahead of Aspen Ideas: Climate, we caught up with Andrea Rodgers, Senior Attorney at Our Children's Trust,...
History has the power to teach us what to do in the present, but do we actually make good use of that tool? Many events in our recent past might suggest otherwise. American hi...
Of course, Black history shouldn’t just be a month-long nod on our yearly calendar — it is inextricable from American history and fundamental to the very soul of our nation an...
The unflinching humanity and morality that Martin Luther King, Jr. embodied is part of what makes his legacy so lasting. In addition to his preeminent civil rights work, he sp...
The stories we hear about migrants trying to escape difficult circumstances tend to focus on hardship, conflict, statistics and policy. We rarely get a deep look at any of the...
Most Americans today would agree that the dream of supporting a family and living a good life on one full time salary is not available to vast numbers of people. Wages have no...
Climate change catastrophes are already happening with increasing regularity, and it’s clear we need to take action. The Biden administration has set a target of zero carbon e...
Even when the economy is booming and unemployment is low, millions of Americans still face economic hardship. And in the last few years the United States has dealt with supply...
Almost everyone agrees that immigration policy in the United States is lacking, but despite decades of debate, Congress has not been able to pass comprehensive reform on the i...
Americans seem more culturally and ideologically divided than at any point in most of our lifetimes, with no prospect of bridging those divides any time soon. The only thing w...
It’s a fact: In communities where voting rates are higher, health outcomes are better. That’s why ER physician Alister Martin, the Founder of Vot-ER and CEO of A Healthier Dem...
Populations around the world have been electing more and more autocratic leaders in the past couple decades, via supposedly free, fair, and democratic elections. The freedom o...
Merely defining gun violence is difficult, and coming to agreement on what to do about it often seems near-impossible in the United States. But people on all sides of the deba...
The U.S. Supreme Court continues to issue major decisions that have profound impacts on the lives of Americans and the political future of the country. During the term that ju...
At the 2023 Aspen Ideas Festival, we dug into some of the most important and fascinating issues of our time, from rebuilding trust in our institutions and the promise and peri...
If one dives deeply into the statistics, the American Dream is actually quite alive and well. In his provocative book, The Myth of American Inequality, former U.S. senator Phi...
How do we describe the Republican Party today, and what are the dynamics that will shape its future?
In their new book, co-authors and Stanford professors Rob Reich and Mehran Sahami argue that big tech’s obsession with optimization and efficiency has sacrificed fundamental h...